Avedro Inks $25M Series C

Waltham, Mass.-based Avedro Inc. has closed on $25 million Series C financing. SCP Vitalife led the round along with Aperture Venture Partners. Existing investors Prism VentureWorks, De Novo Ventures, Flagship Ventures, Borealis Ventures and Echelon Ventures also participated in the round. The company, a developer of systems and procedures for biomechanically strengthening and modifying the cornea, plans to use the funding to expand its commercial operation outside the U.S. As a result of the round, Jeff Dykan of SCP Vitalife will join the Avedro board. Eric Sillman of Aperture Venture Partners joins as an observer.

North AmericaUSBriefs